Back to UBS Group AG UBS Group AG

LTRNLTRN
25 quarters

Position history for UBS Group AGUBS Group AG's holdings in LANTERN PHARMA INC

UBS Group AG holds 16,632 shares of LTRN (LANTERN PHARMA INC), worth $69,355 as of 2026-Q2. The position was increased (+65.0% shares).

Current Value

$69,355

Current Shares

16,632

Total Value Change

+$50,355

Total Shares Change

+15,099

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
16,632
+65.0%
$69,3550.0%$4.17
21
2026-Q1
Decreased
10,077
-5.2%
$13,8050.0%$2.71
0
2025-Q4
Decreased
10,627
-68.0%
$32,2000.0%$3.06
0
2025-Q3
Increased
33,156
+34.5%
$144,2280.0%$4.54
20
2025-Q2
Decreased
24,653
-12.2%
$77,9030.0%$3.19
0
2025-Q1
Increased
28,091
+1.5%
$99,4430.0%$3.55
15
2024-Q4
Increased
27,684
+3.0%
$88,3120.0%$3.27
15
2024-Q3
Increased
26,871
+5.4%
$98,6170.0%$3.78
16
2024-Q2
Unchanged
25,500
0.0%
$119,0850.0%$4.67
0
2024-Q1
Decreased
25,500
-1.8%
$224,4000.0%$8.80
0
2023-Q4
Decreased
25,958
-3.9%
$111,1000.0%$4.28
0
2023-Q3
Unchanged
27,000
0.0%
$92,0700.0%$3.41
0
2023-Q2
Unchanged
27,000
0.0%
$152,2800.0%$5.15
0
2023-Q1
Increased
27,000
+81.9%
$130,4100.0%$4.67
23
2022-Q4
Increased
14,841
+23.7%
$89,6400.0%$6.04
18
2022-Q3
Decreased
12,000
-0.4%
$57,0000.0%$4.79
0
2022-Q2
Decreased
12,050
-13.5%
$69,0000.0%$5.35
0
2022-Q1
Increased
13,936
+6.3%
$100,0000.0%$7.15
16
2021-Q4
Increased
13,110
+70.8%
$105,0000.0%$7.24
22
2021-Q3
Decreased
7,677
-6.9%
$86,0000.0%$11.03
0
2021-Q2
Increased
8,244
+280.6%
$121,0000.0%$14.90
24
2021-Q1
New
2,166
-
$39,0000.0%$18.02
31
2020-Q4
Exited
0
-100.0%
$00.0%$19.33
0
2020-Q3
Decreased
112
-92.7%
$2,0000.0%$20.40
0
2020-Q2
New
1,533
-
$19,0000.0%$12.30
28

Other major holders of LTRN: NewEdge Advisors, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used